A recent longitudinal observational cohort study investigated the impact of use of disease-modifying antirheumatic drugs (DMARDs), statins, proton...
30 Jul, 2019
Transient osteoporosis of hip (TOH) is a self-limiting idiopathic condition and requires 6-12 months for the resolution of symptoms. There is...
25 Jul, 2019
Osteoporotic hip fracture is a serious medical problem with a significant burden on the healthcare system. Use of osteoanabolic agents for...
09 Jul, 2019
Active rheumatoid arthritis (RA) patients with and without renal insufficiency (the ACTRA-RI study) is an ongoing multicentre cohort consisting of...
05 Jul, 2019
Prevalence of atypical femoral fractures (AFF) induced by long-term treatment with bisphosphonates, ranges between 3.22 and 113.1 cases per 100,000...
This study determined the incidence of adverse drug reactions (ADRs) and factors associated with the safety and efficacy of adalimumab in Japanese...
ABILITY-3 study is a randomized controlled trial evaluating the safety and efficacy of continuing versus withdrawing adalimumab therapy in patients...
This is the first large contemporary analysis of real-world clinical practice that compared the risk of cardiovascular events among hip fracture...
Systemic Lupus Erythematosus (SLE) is an inflammatory disease caused when the immune system attacks body’s own tissues. This leaflet gives an overvie...
Eating foods rich in calcium and vitamin D may help prevent bones from becoming weak and less likely to fracture. This article gives a list of food...
Calcium and vitamin D are two essential nutrients long known for their roles in maintaining bone health. This article gives comprehensive recommended...
This datasheet covers the rationale for Risofos kit formulation, its composition, dosage and administration information.
This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...
This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.
Risendronate 150 mg is used for the management of osteoporosis. This monograph provides information on its basic pharmacology, clinical efficacy...
The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...
This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...
Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...
This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...